在通道的选择性过器中,胺基替代以的结构和功能后果
Francis I Valiyaveetil1, Matthew Sekedat, Roderick MacKinnon
1Laboratory of Molecular Neurobiology and Biophysics, The Rockefeller University, New York, New York 10021, USA.
Journal of the American Chemical Society
|August 31, 2006
概括
修改KcsA通道的方法
科学领域:
- 生物物理学的生物物理.
- 结构生物学 结构生物学
- 离子通道功能的功能
背景情况:
- (K+) 通道对于细胞功能至关重要.
- 它们的选择性过器含有四个结合位点 (S1-S4),通常有两个K+离子.
- 最佳的离子流量发生在不同部位的结合能量平衡时.
研究的目的:
- 研究KcsA通道的选择性过器中的扰乱结合点1如何影响K+导电.
- 了解离子分布和离子间隔在通道功能中的作用.
主要方法:
- 蛋白质半合成被用来在KcsA通道的第1位点引入胺基与的替代.
- 分析了K+导电特性和离子分布 (K+,Rb+,Cs+).
- 评估了选择性过器的结构完整性.
主要成果:
- 修改改变了过器内的K+导电和离子分布,特别是Rb+.
- 一个新的离子结合部位出现在过器的外部,与部分水离子相关.
- 这导致了改变的离子间距和减少的离子导电率.
结论:
- 选择性过器的结构对于微小的修改是坚固的.
- 离子分布和精确的间距对于高效的通道功能至关重要.
- KcsA通道的选择性过器针对离子占用率和离子间距离进行了优化.
相关概念视频
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic antagonists are called...
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Ion Exchange
Ion exchange chromatography separates charged molecules from a solution by reversibly exchanging them with mobile, or 'active', ions associated with the oppositely charged stationary phase. This method can be used to separate ions, soften and deionize water, and purify solutions. The polymers comprising the ion-exchange column are high-molecular-weight and chemically stable polymers, crosslinked to be porous and essentially insoluble. They are also functionalized with either acidic or basic...
Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...


